Holds one active US DMF and 2 valid CEPs for lamivudine, filing since 2008. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
EDQM certificate database
FDA, List of Drug Master Files
Holds one active US DMF and 2 valid CEPs for lamivudine, filing since 2008. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF and one valid CEP for lamivudine, filing since 2009. Its 2024 FDA inspection closed as VAI.
Holds one active US DMF for lamivudine, filing since 2013. Its 2024 FDA inspection closed as NAI.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountThis page filters the worldwide Lamivudine manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free